Exact Sciences (EXAS) Stock Price, Quote, News & History

Q: What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Exact Sciences (EXAS) Stock Price, Quote, News & History

EXASNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$102.53

0.030.03%

Last update: Feb 3, 9:35 AM

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$102.52

Close

-

Volume / Avg.

41.92K / 5.38M

Day Range

$102.48 - $102.55

52 Wk Range

38.81 - 102.66

Market Cap

$19.46B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

5.14%

Days to Cover

3.38

Recent Exact Sciences Corp News

Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints

Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast higher full-year profits and steady sales growth.

Vandana Singh

This Domino's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Avi Kapoor

Top 2 Health Care Stocks That May Crash In Q1

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

386.81M

Investing Cash Flow (TTM)

62.13M

Financing Cash Flow (TTM)

-251.72M

Free Cash Flow (TTM)

247.08M

Capital Expenditure (TTM)

-139.73M

Net Change in Cash (TTM)

197.23M

Analyst Trends and Forecast

4

1

Aug 25

1

Sep 25

4

Oct 25

9

5

Nov 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$20.98B

PE Ratio (TTM)

-

PE Ratio (FWD)

185.19

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.24

PB Ratio (TTM)

7.78

Earnings Yield % (TTM)

-5.22%

Earnings Yield % (FWD)

0.54%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

77.82

Book Value / Share

$13.17

Company Debt

Total Debt

$2.33B

LT Debt

$2.33B

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$249.17M

Total Cash

$789.04M

Debt to Equity

1.01

Issuance of Debt (TTM)

-$249.17M

Repayment of Debt (TTM)

-$249.17M

Key Statistics

Open

$102.52

Close

-

Volume / Avg.

41.92K / 5.38M

Day Range

$102.48 - $102.55

52 Wk Range

38.81 - 102.66

Market Cap

$19.46B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

5.14%

Days to Cover

3.38

About

Sector

Health Care

Industry

Biotechnology

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The co...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Exact Sciences (EXAS) stock?

A

You can purchase shares of Exact Sciences (NASDAQ:EXAS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Exact Sciences (EXAS) competitors?

A

Other companies in Exact Sciences’s space includes: Avidity Biosciences Inc (NASDAQ:RNA), BeOne Medicines Ltd (NASDAQ:ONC), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Roivant Sciences Ltd (NASDAQ:ROIV).

Q

What is the forecast, or price target, for Exact Sciences (EXAS) stock?

A

Exact Sciences has a consensus price target of $83.52.

Q

What is the current price for Exact Sciences (EXAS)?

A

The stock price for Exact Sciences (NASDAQ: EXAS) is $102.53 last updated February 3, 2026 at 9:35 AM EST.

Q

Does Exact Sciences (EXAS) pay a dividend?

A

There are no upcoming dividends for Exact Sciences.

Q

When is Exact Sciences (NASDAQ:EXAS) reporting earnings?

A

Exact Sciences does not have any upcoming earnings scheduled.

Q

Is Exact Sciences (EXAS) going to split?

A

There is no upcoming split for Exact Sciences.

Q

What sector and industry does Exact Sciences (EXAS) operate in?

A

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Avidity Biosciences Inc

Neurocrine Biosciences Inc

Ionis Pharmaceuticals Inc

United Therapeutics Corp

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$102.52

Close

-

Volume / Avg.

41.92K / 5.38M

Day Range

$102.48 - $102.55

52 Wk Range

38.81 - 102.66

Market Cap

$19.46B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

5.14%

Days to Cover

3.38

Recent Exact Sciences Corp News

Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints

Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast higher full-year profits and steady sales growth.

Vandana Singh

This Domino's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Avi Kapoor

Top 2 Health Care Stocks That May Crash In Q1

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

386.81M

Investing Cash Flow (TTM)

62.13M

Financing Cash Flow (TTM)

-251.72M

Free Cash Flow (TTM)

247.08M

Capital Expenditure (TTM)

-139.73M

Net Change in Cash (TTM)

197.23M

Analyst Trends and Forecast

4

1

Aug 25

1

Sep 25

4

Oct 25

9

5

Nov 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$20.98B

PE Ratio (TTM)

-

PE Ratio (FWD)

185.19

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.24

PB Ratio (TTM)

7.78

Earnings Yield % (TTM)

-5.22%

Earnings Yield % (FWD)

0.54%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

77.82

Book Value / Share

$13.17

Company Debt

Total Debt

$2.33B

LT Debt

$2.33B

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$249.17M

Total Cash

$789.04M

Debt to Equity

1.01

Issuance of Debt (TTM)

-$249.17M

Repayment of Debt (TTM)

-$249.17M

Key Statistics

Open

$102.52

Close

-

Volume / Avg.

41.92K / 5.38M

Day Range

$102.48 - $102.55

52 Wk Range

38.81 - 102.66

Market Cap

$19.46B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

5.14%

Days to Cover

3.38

About

Sector

Health Care

Industry

Biotechnology

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The co...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry